Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease

BACKGROUND: Multiple biomarkers have been independently and additively associated with major adverse cardiovascular events in patients with coronary artery disease. We investigated the prognostic value of suPAR (soluble urokinase‐type plasminogen activator receptor) and hsTnI (high‐sensitivity tropo...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Badri, Ahmed, Tahhan, Ayman Samman, Sabbak, Nabil, Alkhoder, Ayman, Liu, Chang, Ko, Yi‐An, Vaccarino, Viola, Martini, Afif, Sidoti, Arianna, Goodwin, Cydney, Ghazzal, Bahjat, Beshiri, Agim, Murtagh, Gillian, Mehta, Puja K., Quyyumi, Arshed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428519/
https://www.ncbi.nlm.nih.gov/pubmed/32301366
http://dx.doi.org/10.1161/JAHA.119.015515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428519/
https://www.ncbi.nlm.nih.gov/pubmed/32301366
http://dx.doi.org/10.1161/JAHA.119.015515

Ejemplares similares